Afficher la notice abrégée

dc.contributor.authorHofman, Paul*
dc.contributor.authorCalin, George*
dc.contributor.authorMani, Sendurai*
dc.date.accessioned2021-02-12T06:11:01Z
dc.date.available2021-02-12T06:11:01Z
dc.date.issued2019*
dc.date.submitted2019-12-09 11:49:15*
dc.identifier42519*
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/61058
dc.description.abstractThis Special Issue of Cancers (Basel) is mainly dedicated to selecting papers from the talks given during the first Joint Meeting on Lung Cancer (JMLC) between the MD Anderson Cancer Center (Houston, Texas USA) and the Hospital University Federation (HUF) OncoAge (University Côte d’Azur, Nice, France) (Nice, September 2018). The central theme of JMLC is to discuss new advances and exchange ideas regarding lung cancer. Notably, the talks covered different topics on new therapeutic strategies (targeted therapy and immuno-oncology), molecular and cellular biology, biomarkers, and the epidemiology of lung cancer. Special attention was also given to lung cancer in elderly patients. The articles published in this Special Issue covered subjects such as the assessment of new biomarkers and new approaches for the early detection of lung cancer, epidemiological data, and emphasized a place for the newly characterized cellular pathways in lung cancer, which opens room for therapeutic perspectives for lung cancer patients.*
dc.languageEnglish*
dc.subjectR5-920*
dc.subjectRC254-282*
dc.subject.classificationthema EDItEUR::M Medicine and Nursingen_US
dc.subject.othermicroRNAs*
dc.subject.othermultiplexed*
dc.subject.otherscreening*
dc.subject.othereducation*
dc.subject.othernon-smoker*
dc.subject.otherimage analysis*
dc.subject.otherartificial intelligence*
dc.subject.otherresearch*
dc.subject.otherlung cancer*
dc.subject.otherspatial analysis*
dc.subject.otheroptimization*
dc.subject.otherfluorescence*
dc.subject.othergeriatric assessment*
dc.subject.othergeriatric interventions*
dc.subject.otherTNBC*
dc.subject.otherliquid biopsy*
dc.subject.othernon-small cell lung cancer*
dc.subject.otherintegrated approaches*
dc.subject.otherwell-being*
dc.subject.otherhormone-like action*
dc.subject.otherEGFR mutations*
dc.subject.otherreversal of EMT*
dc.subject.othertumor plasticity*
dc.subject.otherimmune profiling*
dc.subject.othermacrophage*
dc.subject.othermultiplexed methodologies*
dc.subject.othertargeted treatment*
dc.subject.othertechniques*
dc.subject.otherimmune-oncology*
dc.subject.otherbioinformatics*
dc.subject.otherMALAT1*
dc.subject.otherlong non-coding RNAs*
dc.subject.otherCD8 T Cells*
dc.subject.otherpersonal medicine*
dc.subject.otherEGFR TKIs*
dc.subject.otherlncRNA*
dc.subject.otherhormones*
dc.subject.otherelderly*
dc.subject.otherinterleukin-1? and immunometabolism*
dc.subject.otherchromogenic*
dc.subject.otherxenograft*
dc.subject.othermetastasis*
dc.subject.otherPD-1/PD-L1 checkpoint blockade*
dc.subject.otherimmunotherapy*
dc.subject.othermolecular*
dc.subject.othercancer tissues*
dc.subject.otherdigital*
dc.subject.otherNSCLC*
dc.subject.otherimmune blockade*
dc.subject.otherlung adenocarcinoma*
dc.subject.othercirculating tumor cells*
dc.subject.otherbrightfield*
dc.subject.othernon-coding RNAs*
dc.subject.otherolder adults*
dc.subject.othercancer*
dc.subject.othertumor microenvironment*
dc.subject.otheraging*
dc.subject.otherrational therapy*
dc.titleTowards New Promising Discoveries for Lung Cancer Patients: A Selection of Papers from the First Joint Meeting on Lung Cancer of the FHU OncoAge (Nice, France) and the MD Anderson Cancer Center (Houston, TX, USA)*
dc.typebook
oapen.identifier.doi10.3390/books978-3-03921-452-5*
oapen.relation.isPublishedBy46cabcaa-dd94-4bfe-87b4-55023c1b36d0*
oapen.relation.isbn9783039214525*
oapen.relation.isbn9783039214518*
oapen.pages230*
oapen.edition1st*


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by-nc-nd/4.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by-nc-nd/4.0/